home / stock / axsm / axsm quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-01 | 67.28 | 69.2 | 71.74 | 66.54 | 473,108 |
2021-02-26 | 68.33 | 67.36 | 69.75 | 66.01 | 328,854 |
2021-02-25 | 71.36 | 68.38 | 72.75 | 68.17 | 280,025 |
2021-02-24 | 70.58 | 71.98 | 72.04 | 69.4 | 227,081 |
2021-02-23 | 69 | 69.93 | 70.7 | 66.104 | 393,361 |
2021-02-22 | 71.98 | 69.43 | 72.07 | 69.2 | 244,350 |
2021-02-19 | 71.52 | 72.27 | 73.15 | 71.26 | 290,048 |
2021-02-18 | 71.3 | 71.18 | 72.28 | 70.01 | 330,234 |
2021-02-17 | 73.94 | 72.02 | 74.2384 | 71.38 | 277,110 |
2021-02-16 | 75.25 | 74.71 | 75.855 | 74.1 | 243,250 |
2021-02-15 | 73.75 | 74.63 | 74.94 | 72.03 | 275,098 |
2021-02-12 | 73.75 | 74.63 | 74.94 | 72.03 | 274,990 |
2021-02-11 | 75.76 | 73.7 | 75.85 | 73.18 | 194,065 |
2021-02-10 | 75.51 | 75 | 76.48 | 72.4 | 176,822 |
2021-02-09 | 75.36 | 75.05 | 77.08 | 74.95 | 215,488 |
2021-02-08 | 76.15 | 75.27 | 77.25 | 74.71 | 246,455 |
2021-02-05 | 76.54 | 75.25 | 76.62 | 73.95 | 216,489 |
2021-02-04 | 75.93 | 75.88 | 78 | 75.0001 | 298,475 |
2021-02-03 | 73.9 | 75.53 | 75.64 | 73.53 | 216,138 |
2021-02-02 | 72 | 73.73 | 73.9887 | 71.94 | 251,387 |
Axsome Therapeutics Inc. Company Name:
AXSM Stock Symbol:
NASDAQ Market:
Axsome Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Bitcoin and other cryptocurrencies are all the rage these days, and many investors are thinking of jumping on the bandwagon. Some Bitcoin optimists believe that it will replace fiat currency, that is, government-issued (or government-backed) currency whose value isn't linked to any comm...
Axsome Therapeutics (NASDAQ: AXSM) was a penny stock at the end of 2018. Shares dropped all the way to $1.94 on Dec. 27. If you invested $20,000 in Axsome on that day, you'd have 10,309 shares. And if you held on to those shares, a year later you would have been a millionaire. Y...
ACCORD is the second pivotal trial of AXS-05 in Alzheimer’s disease agitation No treatments are currently approved for Alzheimer’s disease agitation NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical compan...